Recruiting studies: Cavernous Malformations

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Alpelisib in Pediatric and Adult Patients With Lymphatic Malformations Associated With a PIK3CA Mutation.
Phase 2/Phase 3 · 60 location(s) · Novartis Pharmaceuticals · NCT05948943 Quantitative Susceptibility Biomarker and Brain Structural Property for Cerebral Cavernous Malformation Related Epilepsy
Phase N/A · 2 location(s) · yuanli Zhao · NCT04076449 Hemorrhagic Brainstem Cavernous Malformations Treatment With Sirolimus: aSingle Centre, Randomized, Placebo-controlled P
Phase 2 · 2 location(s) · Huashan Hospital · NCT06091332 Natural History of Familial Cerebral Cavernous Malformations: the CCM_Italia Cohort Study
Phase N/A · 6 location(s) · Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · NCT06983132 Study on Treatment Decision-Making and Prognostic Follow-Up for Untreated Cerebral Cavernous Malformations
Phase N/A · 1 location(s) · Beijing Tiantan Hospital · NCT06214767

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.